Recombinant human thrombopoietin promotes platelet recovery in DCAG-treated patients with intermediate-high-risk MDS/hypoproliferative AML.
- Resource Type
- Article
- Source
- Medicine; 3/31/2023, Vol. 102 Issue 13, pe33373-e33373, 1p
- Subject
- Language
- ISSN
- 00257974